Regulations Review Program Under Executive Order 12866

Özet

The Food and Drug Administration (FDA) is announcing its plan to review significant regulations pursuant to Executive Order 12866, which requires all Federal agencies to develop a program for periodically reviewing existing significant regulations. Under this program, the agency will determine whether its regulations need to be refined to achieve their public health goals more effectively or to avoid unnecessary burdens.